| Optimization of novel monobactams with activity against carbapenem-resistant Enterobacteriaceae–identification of LYS228 F Reck, A Bermingham, J Blais, V Capka, T Cariaga, A Casarez, R Colvin, ... Bioorganic & medicinal chemistry letters 28 (4), 748-755, 2018 | 59 | 2018 |
| Mutations linked to neurological disease enhance self-association of low-complexity protein sequences X Zhou, L Sumrow, K Tashiro, L Sutherland, D Liu, T Qin, M Kato, ... Science 377 (6601), eabn5582, 2022 | 46 | 2022 |
| IID572: a new potentially best-in-class β-lactamase inhibitor F Reck, A Bermingham, J Blais, A Casarez, R Colvin, CR Dean, ... ACS infectious diseases 5 (7), 1045-1051, 2019 | 26 | 2019 |
| Serine ADP-ribosylation marks nucleosomes for ALC1-dependent chromatin remodeling J Mohapatra, K Tashiro, RL Beckner, J Sierra, JA Kilgore, NS Williams, ... Elife 10, e71502, 2021 | 24 | 2021 |
| Discovery and optimization of DNA gyrase and topoisomerase IV inhibitors with potent activity against fluoroquinolone-resistant gram-positive bacteria G Lapointe, CK Skepper, LM Holder, D Armstrong, C Bellamacina, J Blais, ... Journal of Medicinal Chemistry 64 (9), 6329-6357, 2021 | 14 | 2021 |
| Chemoenzymatic and synthetic approaches to investigate aspartate-and glutamate-ADP-ribosylation K Tashiro, S Wijngaarden, J Mohapatra, JGM Rack, I Ahel, DV Filippov, ... Journal of the American Chemical Society 145 (25), 14000-14009, 2023 | 10 | 2023 |
| A protein semisynthesis-based strategy to investigate the functional impact of linker histone serine ADP-ribosylation K Tashiro, J Mohapatra, CA Brautigam, G Liszczak ACS chemical biology 17 (4), 810-815, 2022 | 9 | 2022 |
| Development and Application of Chemoenzymatic Tools to Investigate Site-Specific Protein ADP-Ribosylation K Tashiro | | 2023 |
| A protein semisynthesis-based strategy to probe the impact of site-specific serine ADP-ribosylation on linker histone function K Tashiro, J Mohapatra, CA Brautigam, G Liszczak bioRxiv, 2022.02. 17.480967, 2022 | | 2022 |
| Tracing the genetics of neurological disease to the mutation-directed addition of single hydrogen bonds X Zhou, K Tashiro, L Sumrow, L Sutherland, G Liszczak, SL McKnight bioRxiv, 2021.12. 05.471334, 2021 | | 2021 |
